U.S. pharma giant copyright scrapped two experimental weight loss tablets last yr—a at the time-daily tablet, lotiglipron, as a result of elevated liver enzymes plus a 2 times-each day capsule, danuglipron, due to powerful side effects—but CEO Albert Bourla has reported the company is determined to “play and gain” inside the obesity Place A… Read More